vs
Aurinia Pharmaceuticals Inc.（AUPH）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是Aurinia Pharmaceuticals Inc.的1.5倍（$117.7M vs $77.1M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs -10.8%，领先284.1%），Aurinia Pharmaceuticals Inc.同比增速更快（28.8% vs -19.2%），过去两年Aurinia Pharmaceuticals Inc.的营收复合增速更高（23.8% vs -11.8%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
AUPH vs RGP — 直观对比
营收规模更大
RGP
是对方的1.5倍
$77.1M
营收增速更快
AUPH
高出48.0%
-19.2%
净利率更高
AUPH
高出284.1%
-10.8%
两年增速更快
AUPH
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $117.7M |
| 净利润 | $210.8M | $-12.7M |
| 毛利率 | 88.6% | 37.1% |
| 营业利润率 | 43.1% | -10.3% |
| 净利率 | 273.4% | -10.8% |
| 营收同比 | 28.8% | -19.2% |
| 净利润同比 | 14651.2% | 81.6% |
| 每股收益（稀释后） | $1.52 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRGP
| Q4 25 | $77.1M | $117.7M | ||
| Q3 25 | $73.5M | $120.2M | ||
| Q2 25 | $70.0M | $139.3M | ||
| Q1 25 | $62.5M | $129.4M | ||
| Q4 24 | $59.9M | $145.6M | ||
| Q3 24 | $67.8M | $136.9M | ||
| Q2 24 | $57.2M | $148.2M | ||
| Q1 24 | $50.3M | $151.3M |
净利润AUPHRGP
| Q4 25 | $210.8M | $-12.7M | ||
| Q3 25 | $31.6M | $-2.4M | ||
| Q2 25 | $21.5M | $-73.3M | ||
| Q1 25 | $23.3M | $-44.1M | ||
| Q4 24 | $1.4M | $-68.7M | ||
| Q3 24 | $14.3M | $-5.7M | ||
| Q2 24 | $722.0K | $10.5M | ||
| Q1 24 | $-10.7M | $2.5M |
毛利率AUPHRGP
| Q4 25 | 88.6% | 37.1% | ||
| Q3 25 | 88.9% | 39.5% | ||
| Q2 25 | 89.8% | 40.2% | ||
| Q1 25 | 86.3% | 35.1% | ||
| Q4 24 | 90.7% | 38.5% | ||
| Q3 24 | 91.1% | 36.5% | ||
| Q2 24 | 84.4% | 40.2% | ||
| Q1 24 | 84.6% | 37.0% |
营业利润率AUPHRGP
| Q4 25 | 43.1% | -10.3% | ||
| Q3 25 | 40.5% | -1.7% | ||
| Q2 25 | 28.7% | -47.0% | ||
| Q1 25 | 35.0% | -38.4% | ||
| Q4 24 | -2.8% | -52.7% | ||
| Q3 24 | 17.3% | -3.5% | ||
| Q2 24 | -2.6% | 7.6% | ||
| Q1 24 | -26.3% | 2.8% |
净利率AUPHRGP
| Q4 25 | 273.4% | -10.8% | ||
| Q3 25 | 42.9% | -2.0% | ||
| Q2 25 | 30.7% | -52.6% | ||
| Q1 25 | 37.4% | -34.0% | ||
| Q4 24 | 2.4% | -47.2% | ||
| Q3 24 | 21.2% | -4.2% | ||
| Q2 24 | 1.3% | 7.1% | ||
| Q1 24 | -21.4% | 1.7% |
每股收益（稀释后）AUPHRGP
| Q4 25 | $1.52 | $-0.38 | ||
| Q3 25 | $0.23 | $-0.07 | ||
| Q2 25 | $0.16 | $-2.21 | ||
| Q1 25 | $0.16 | $-1.34 | ||
| Q4 24 | $0.00 | $-2.08 | ||
| Q3 24 | $0.10 | $-0.17 | ||
| Q2 24 | $0.01 | $0.31 | ||
| Q1 24 | $-0.07 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $581.3M | $194.6M |
| 总资产 | $751.6M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AUPHRGP
| Q4 25 | $80.2M | $89.8M | ||
| Q3 25 | $72.9M | $77.5M | ||
| Q2 25 | $52.9M | $86.1M | ||
| Q1 25 | $66.1M | $72.5M | ||
| Q4 24 | $83.4M | $78.2M | ||
| Q3 24 | $36.6M | $89.6M | ||
| Q2 24 | $33.3M | $108.9M | ||
| Q1 24 | $63.9M | $113.8M |
股东权益AUPHRGP
| Q4 25 | $581.3M | $194.6M | ||
| Q3 25 | $365.8M | $206.4M | ||
| Q2 25 | $335.3M | $207.1M | ||
| Q1 25 | $350.2M | $277.8M | ||
| Q4 24 | $377.5M | $325.7M | ||
| Q3 24 | $388.0M | $407.2M | ||
| Q2 24 | $364.6M | $418.8M | ||
| Q1 24 | $359.5M | $414.9M |
总资产AUPHRGP
| Q4 25 | $751.6M | $289.3M | ||
| Q3 25 | $527.5M | $287.2M | ||
| Q2 25 | $502.6M | $304.7M | ||
| Q1 25 | $504.9M | $375.6M | ||
| Q4 24 | $550.6M | $424.9M | ||
| Q3 24 | $549.4M | $512.9M | ||
| Q2 24 | $523.5M | $510.9M | ||
| Q1 24 | $516.6M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | — | $15.6M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
经营现金流AUPHRGP
| Q4 25 | $45.7M | $15.9M | ||
| Q3 25 | $44.4M | $-7.8M | ||
| Q2 25 | $44.2M | $16.8M | ||
| Q1 25 | $1.3M | $659.0K | ||
| Q4 24 | $30.1M | $1.8M | ||
| Q3 24 | $17.0M | $-309.0K | ||
| Q2 24 | $15.8M | $3.2M | ||
| Q1 24 | $-18.6M | $20.5M |
自由现金流AUPHRGP
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | — | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | — | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $20.4M |
自由现金流率AUPHRGP
| Q4 25 | — | 13.2% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度AUPHRGP
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率AUPHRGP
| Q4 25 | 0.22× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 21.07× | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 21.94× | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
